Vicore Pharma Holding AB Share Price
NASDAQ: VCRE$9.18
+$9.18 (--%) Last updated on 13 Oct, 2026 | 01:29 ISTVicore Pharma Holding AB Stock Performance
Vicore Pharma Holding AB Share Price Chart
$9.28$9.38
L
H
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
Vicore Pharma Holding AB Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $9.53 | $9.28 | -9.29% |
Sep 2026 | $11.68 | $10.23 | -16.22% |
Aug 2026 | $12.22 | $12.21 | +7.20% |
Jul 2026 | $17.50 | $11.39 | N/A |
VCRE Share Price FAQs
What is Vicore Pharma Holding AB share price today?
Vicore Pharma Holding AB share price today is $9.18 as on October 13, 2026 at 1:29 am IST.
What is the 52 week high and 52 week low of Vicore Pharma Holding AB stock?
The 52 week high of Vicore Pharma Holding AB stock is $17.56, while the 52 week low is $8.20 as of 13 Oct '26.
What is the 5 year returns of VCRE?
The 5 year returns of VCRE is -19.40% as on 13 Oct '26.
What is the high & low stock price of VCRE today?
VCRE stock price hit a high of $9.38 and low of $9.28 as of 13 Oct '26.
Can I buy VCRE shares in India?
Yes. You can buy VCRE in India by opening an international trading account.